Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Cao

Showing results (751-760 of 768) with videos related to

Pageof 77
Sort By:
Emerging Microbes & Infections|November 12, 2025
Antiviral treatment response to nucleos(t)ide analogues in chronic hepatitis B patients with normal alanine aminotransferase levels: a retrospective multi-center studyFei Cao, Jian Wang, Ye Xiong, et al.
Schizophrenia Research|April 5, 2025
Association between serum bilirubin and type 2 diabetes mellitus risk: Findings from a schizophrenia cohortKuan Liu, Hao-Wen Chen, Shi-Ao Wang, et al.
Nature Communications|March 12, 2024
Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trialDi Wu, Yong Li, Pengfei Xu, et al.
Frontiers in Chemistry|September 15, 2022
Pseudo-resonance structures in chiral alcohols and amines and their possible aggregation statesHuajie Zhu, Shengnan Li, Yunjing Jia, et al.
Environmental Pollution (Barking, Essex : 1987)|May 18, 2025
Independent and joint effects of volatile organic compounds on pulmonary function in U.S. adults from NHANES: the mediating role of platelet-to-lymphocyte ratioYan-Fei Wei, Hao-Wen Chen, Kuan Liu, et al.
QJM : Monthly Journal of the Association of Physicians|September 19, 2025
Extreme Gradient Boosting-based Explainable Machine Learning Model for Predicting Significant Fibrosis in Autoimmune HepatitisZhiyi Zhang, Jing Wu, Jian Wang, et al.
Emerging Microbes & Infections|April 8, 2024
Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNAJian Wang, Li Zhu, Shaoqiu Zhang, et al.
Atherosclerosis|June 25, 2025
Impact of baseline and trajectory of the cardiometabolic indices on incident microvascular complications in patients with type 2 diabetesBi-Fei Cao, Kuan Liu, Hao-Wen Chen, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2024
Favourable Prognosis of Patients With Untreated HBeAg-Negative Chronic Hepatitis B Virus Infection With HBsAg < 100 IU/mLJian Wang, Zhiyi Zhang, Shengxia Yin, et al.
Immunity|March 13, 2024
Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8<sup>+</sup> T cell effector functionsJingjing Cong, Pianpian Liu, Zili Han, et al.
Pageof 77

Showing results (751-760 of 768) with videos related to

Sort By:
Pageof 77
Emerging Microbes & Infections|November 12, 2025
Antiviral treatment response to nucleos(t)ide analogues in chronic hepatitis B patients with normal alanine aminotransferase levels: a retrospective multi-center studyFei Cao, Jian Wang, Ye Xiong, et al.
Schizophrenia Research|April 5, 2025
Association between serum bilirubin and type 2 diabetes mellitus risk: Findings from a schizophrenia cohortKuan Liu, Hao-Wen Chen, Shi-Ao Wang, et al.
Nature Communications|March 12, 2024
Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trialDi Wu, Yong Li, Pengfei Xu, et al.
Frontiers in Chemistry|September 15, 2022
Pseudo-resonance structures in chiral alcohols and amines and their possible aggregation statesHuajie Zhu, Shengnan Li, Yunjing Jia, et al.
Environmental Pollution (Barking, Essex : 1987)|May 18, 2025
Independent and joint effects of volatile organic compounds on pulmonary function in U.S. adults from NHANES: the mediating role of platelet-to-lymphocyte ratioYan-Fei Wei, Hao-Wen Chen, Kuan Liu, et al.
QJM : Monthly Journal of the Association of Physicians|September 19, 2025
Extreme Gradient Boosting-based Explainable Machine Learning Model for Predicting Significant Fibrosis in Autoimmune HepatitisZhiyi Zhang, Jing Wu, Jian Wang, et al.
Emerging Microbes & Infections|April 8, 2024
Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNAJian Wang, Li Zhu, Shaoqiu Zhang, et al.
Atherosclerosis|June 25, 2025
Impact of baseline and trajectory of the cardiometabolic indices on incident microvascular complications in patients with type 2 diabetesBi-Fei Cao, Kuan Liu, Hao-Wen Chen, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2024
Favourable Prognosis of Patients With Untreated HBeAg-Negative Chronic Hepatitis B Virus Infection With HBsAg < 100 IU/mLJian Wang, Zhiyi Zhang, Shengxia Yin, et al.
Immunity|March 13, 2024
Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8<sup>+</sup> T cell effector functionsJingjing Cong, Pianpian Liu, Zili Han, et al.
Pageof 77